Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome-Reference-Cited by-同舟云学术

Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome

Published:1994-09 Issue:8 Volume:17 Page:647-652
ISSN:0391-4097
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Vidal-Puig A.,Muñoz-Torres Manuel,Garcia-Calvente C.,Jodar-Gimeno E.,Lardelli P.,Ruiz-Requena M. E.,Escobar-Jiménez F.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/BF03349680.pdf

Reference37 articles.

1. Barbieri R.L., Smith S., Ryan K.J. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril. 49:197, 1988.

2. Barbieri R.L. Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect. Endocrinol. Metab. Clin. North Am. 17: 685, 1989.

3. Vidal-Puig A., Muñoz-Torres M., Escobar-Jiménez F. New approaches to the definition and diagnostic criteria in the polycystic ovary syndrome. Med. Clin. (Barc.) 100: 389, 1993.

4. Rittmaster R.S., Deshwal N., Lehman L. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of Polycystic Ovarian Syndrome. J. Clin. Endocrinol. Metab. 76: 1295, 1993.

5. Tropeano G., Lucisano A., Liberale I., Barini A., Vuolo I.P., Martino G., Menini E., Dell’Acqua S. Insulin, C-Peptide, Androgens, and ß-Endorphin response to oral glucose in patients with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab. 78: 305, 1994.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of the Ovary in the Genesis of Hyperandrogenism;The Ovary;2004

2. Genetic and environmental aspect of polycystic ovary syndrome;Journal of Endocrinological Investigation;2003-11

3. Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome;Metabolism;1998-08

4. Antidiabetic characteristics of dehydroepiandrosterone in animal and human studies;Lessons from Animal Diabetes VI;1996

5. No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide;European Journal of Endocrinology;1995-12